DR. VANCE M. WRIGHT-BROWNE M.D. NPI 1528059227

NPI Details

DR. Vance M. Wright-browne, M.D. is a medical oncology internal medicine in Port Charlotte, FL. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Vance M. Wright-browne, M.D. NPI is 1528059227. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

22395 EDGEWATER DR
PORT CHARLOTTE, FL
ZIP 33980-012
Phone: (941) 766-7222
Fax: (941) 766-1723

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Iron level (HCPCS:83540)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Folic acid level, serum (HCPCS:82746)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Protein measurement, serum (HCPCS:84165)
• Blood test, clotting time (HCPCS:85610)
• Iron binding capacity (HCPCS:83550)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Red blood count, manual test (HCPCS:85044)
• Automated urinalysis test (HCPCS:81003)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Drawing of blood for a medical problem (HCPCS:99195)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Red blood count, automated test (HCPCS:85045)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Uric acid level, blood (HCPCS:84550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Vitamin d-3 level (HCPCS:82306)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Phosphate level (HCPCS:84100)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Urinalysis, manual test (HCPCS:81002)
• Testosterone (hormone) level, total (HCPCS:84403)
• Erythropoietin (protein) level (HCPCS:82668)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Homocysteine (amino acid) level (HCPCS:83090)

The enumeration date for this NPI number is 11/2/2005 and was last updated on 11/24/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.